Oncology Media Relations   Oncology_media_relations@its.jnj.com     Investor contact: Jess Margevich investor-relations@its.jnj.com ...

Experts have warned there is no "one size fits all" response to the growth of ketamine use ...

God bless my wife. If I bump into a running friend, she gets that look you get when you’re about to hear the story of your Aunt Edna’s gall bladder surgery — for the fourth time. Yes, runners speak a ...

Suffolk sees a 251% increase in the number of ketamine users since 2022.

March 15, 2026 expert reaction to conference abstract comparing prostate cancer and breast cancer screening programmes, being presented at the European Association of Urology Cong ...

Today, Page 2 excerpts Chapter 1 ("Food Flight"), about the team's trip back to New York after it won a tense NLCS over the ...

An interdisciplinary team from the University Hospitals Cologne and Bonn have conducted the first prospective study to ...

You probably don’t need me to tell you that due to recent global events, gas and diesel prices have gone up quickly. People are rightly concerned about the cost of filling up their cars. Without ...

A new NHS‑backed menopause pill, Veoza, promises relief from hot flushes and night sweats for women who cannot use HRT in England. But how does this non‑hormonal drug work in the brain, and who will ...

By Dick Wolfsie Guest Columnist More than 98% of teenagers own a cell phone. Most teens admit the first thing they do in the ...

A doctor has warned that going to the toilet too often can 'rewire' your brain and lead to incontinence ...

Annual Congress was host to a renal cell carcinoma abstract session. Dr. Huebner-Resch presented her team’s initial real-world experience using [89 Zr]Zr-girentuximab PET/CT in the routine evaluation ...